Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

Filter your results:

Types

Topics

57806 Results Found

AHASTAT Blog: Hospitals and 340B program help preserve, protect the safety-net

Hospitals, including those participating in the 340B Drug Pricing Program, are the true safety-net, not the pharmaceutical industry with its “skyrocketing prescription drug prices and huge profits,

HRSA webinar tomorrow to discuss 340B recertification

The Health Resources and Services Administration's Office of Pharmacy Affairs will host a webinar July 20 to assist covered entities with the recertification process for the 340B Drug Pricing Progr

HRSA proposed rule would establish dispute resolution process for 340B program

The Health Resources and Services Administration today released a proposed rule that

Sept. 7 deadline for hospitals to recertify for 340B program

Tomorrow is the last day that hospitals can recertify for the 340B Drug Pricing Program.

AHA calls proposed rule on 340B dispute resolution process 'an important first step'

The Health Resources and Services Administration’s proposed rule that would establish an administrative dispute resolution process for the 340B Drug Pricing Program “is an important first step for

HRSA issues final rule on 340B drug ceiling prices, manufacturer penalties

The Health Resources and Services Administration today released a final rule on drug

340B omnibus guidance withdrawn

The administration yesterday withdrew the Health Resources and Services Administration’s pending omnibus g

HRSA delays effective date of final rule on 340B drug ceiling prices to March 21

The Health Resources and Services Administration today delayed, in accordance with a rece

Preserve the 340B program

Every day, we see stories about the exorbitant costs of prescription drugs and the serious challenges they pose for individuals and the entire health care system.

AHA Stat blog: Congress should protect the 340B program

“Congress should preserve the 340B Drug Pricing Program and protect patients and communities,” writes AHA Executive Vice President Tom Nickels in an AHA Stat